Effects of IL-7 on memory CD8+ T cell homeostasis are influenced by the timing of therapy in mice

Journal of Clinical Investigation

Volumn 118, Issue 3, 2008, Pages 1027-1039

  Nanjappa, Som G ^a   Walent, Jane H ^a   Morre, Michel ^b   Suresh, M ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b Cytheris   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; RECOMBINANT INTERLEUKIN 7;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; HOMEOSTASIS; IMMUNITY; IMMUNOTHERAPY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS INFECTION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; HOMEOSTASIS; IMMUNOLOGIC MEMORY; INTERLEUKIN-7; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS; MICE; MICE, INBRED C57BL; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VACCINES, DNA; VIRAL VACCINES;

EID: 40549091270     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI32020     Document Type: Article

References (54)

1. Seder, R.A., and Ahmed, R. 2003. Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat. Immunol. 4:835-842.
2. Kaech, S.M., Wherry, E.J., and Ahmed, R. 2002. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2:251-262.
3. Ma, A., Koka, R., and Burkett, P. 2006. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 24:657-679.
4. Fry, T.J., and Mackall, C.L. 2002. Interleukin-7: from bench to clinic. Blood. 99:3892-3904.
5. Schluns, K.S., Kieper, W.C., Jameson, S.C., and Lefrancois, L. 2000. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1:426-432.
6. Schluns, K.S., and Lefrancois, L. 2003. Cytokine control of memory T-cell development and survival. Nat. Rev. Immunol. 3:269-279.
7. Osborne, L.C., et al. 2007. Impaired CD8 T cell memory and CD4 T cell primary responses in IL-7R{alpha} mutant mice. J. Exp. Med. 204:619-631.
8. Kaech, S.M., et al. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4:1191-1198.
9. Huster, K.M., et al. 2004. Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets. Proc. Natl. Acad. Sci. U. S. A. 101:5610-5615.
10. Surh, C.D., Boyman, O., Purton, J.F., and Sprent, J. 2006. Homeostasis of memory T cells. Immunol. Rev. 211:154-163.
11. Sasson, S.C., Zaunders, J.J., and Kelleher, A.D. 2006. The IL-7/IL-7 receptor axis: understanding its central role in T-cell homeostasis and the challenges facing its utilization as a novel therapy. Curr. Drug Targets. 7:1571-1582.
12. Snyder, K.M., Mackall, C.L., and Fry, T.J. 2006. IL-7 in allogeneic transplant: clinical promise and potential pitfalls. Leuk. Lymphoma. 47:1222-1228.
13. Rosenberg, S.A., et al. 2006. IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells. J. Immunother. 29:313-319.
14. Ehlken, H., Schadendorf, D., and Eichmuller, S. 2004. Humoral immune response against melanoma antigens induced by vaccination with cytokine gene-modified autologous tumor cells. Int. J. Cancer. 108:307-313.
15. Beq, S., et al. 2006. IL-7 induces immunological improvement in SIV-infected rhesus macaques under antiviral therapy. J. Immunol. 176:914-922.
16. Fry, T.J., et al. 2003. IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. Blood. 101:2294-2299.
17. Melchionda, F., et al. 2005. Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool. J. Clin. Invest. 115:1177-1187.
18. Kieper, W.C., et al. 2002. Overexpression of interleukin (IL)-7 leads to IL-15-independent generation of memory phenotype CD8+ T cells. J. Exp. Med. 195:1533-1539.
19. Fry, T.J., Christensen, B.L., Komschlies, K.L., Gress, R.E., and Mackall, C.L. 2001. Interleukin-7 restores immunity in athymic T-cell-depleted hosts. Blood. 97:1525-1533.
20. Liu, N., et al. 2004. Serine protease inhibitor 2A is a protective factor for memory T cell development. Nat. Immunol. 5:919-926.
21. Maraskovsky, E., et al. 1997. Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1-/- mice. Cell. 89:1011-1019.
22. Zhang, N., and He, Y.W. 2005. The antiapoptotic protein Bcl-xL is dispensable for the development of effector and memory T lymphocytes. J. Immunol. 174:6967-6973.
23. Suresh, M., Singh, A., and Fischer, C. 2005. Role of tumor necrosis factor receptors in regulating CD8 T-cell responses during acute lymphocytic choriomeningitis virus infection. J. Virol. 79:202-213.
24. Wang, X.Z., et al. 2003. Virus-specific CD8 T cells in peripheral tissues are more resistant to apoptosis than those in lymphoid organs. Immunity. 18:631-642.
25. Williams, M.A., Holmes, B.J., Sun, J.C., and Bevan, M.J. 2006. Developing and maintaining protective CD8+ memory T cells. Immunol. Rev. 211:146-153.
26. Moniuszko, M., et al. 2004. Recombinant interleukin-7 induces proliferation of naive macaque CD4+ and CD8+ T cells in vivo. J. Virol. 78:9740-9749.
27. Mazo, I.B., et al. 2005. Bone marrow is a major reservoir and site of recruitment for central memory CD8+ T cells. Immunity. 22:259-270.
28. Murali-Krishna, K., et al. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity. 8:177-187.
29. Fuller, M.J., et al. 2005. Cutting edge: emergence of CD127high functionally competent memory T cells is compromised by high viral loads and inadequate T cell help. J. Immunol. 174:5926-5930.
30. Whitton, J.L., Southern, P.J., and Oldstone, M.B. 1988. Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. Virology. 162:321-327.
31. Tscharke, D.C., et al. 2005. Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines. J. Exp. Med. 201:95-104.
32. Hassett, D.E., Slifka, M.K., Zhang, J., and Whitton, J.L. 2000. Direct ex vivo kinetic and phenotypic analyses of CD8(+) T-cell responses induced by DNA immunization. J. Virol. 74:8286-8291.
33. Rodriguez-Carreno, M.P., et al. 2005. Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein. Virology. 335:87-98.
34. Yokoyama, M., Zhang, J., and Whitton, J.L. 1995. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J. Virol. 69:2684-2688.
35. Hassett, D.E., Zhang, J., and Whitton, J.L. 1999. Plasmid DNA vaccines are effective in the absence of IFNgamma. Virology. 263:175-183.
36. Henson, S.M., Snelgrove, R., Hussell, T., Wells, D.J., and Aspinall, R. 2005. An IL-7 fusion protein that shows increased thymopoietic ability. J. Immunol. 175:4112-4118.
37. Franchimont, D., et al. 2002. Positive effects of glucocorticoids on T cell function by up-regulation of IL-7 receptor alpha. J. Immunol. 168:2212-2218.
38. Hand, T.W., Morre, M., and Kaech, S.M. 2007. Expression of IL-7 receptor alpha is necessary but not sufficient for the formation of memory CD8 T cells during viral infection. Proc. Natl. Acad. Sci. U. S. A. 104:11730-11735.
39. Pellegrini, M., et al. 2004. Loss of Bim increases T cell production and function in interleukin 7 receptor-deficient mice. J. Exp. Med. 200:1189-1195.
40. Opferman, J.T., et al. 2003. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature. 426:671-676.
41. Hildeman, D.A., et al. 2002. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity. 16:759-767.
42. Barata, J.T., et al. 2004. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells. J. Exp. Med. 200:659-669.
43. Li, W.Q., et al. 2006. IL-7 promotes T cell proliferation through destabilization of p27Kip1. J. Exp. Med. 203:573-582.
44. Jiang, Q., et al. 2005. Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev. 16:513-533.
45. Bradley, L.M., Haynes, L., and Swain, S.L. 2005. IL-7: maintaining T-cell memory and achieving homeostasis. Trends Immunol. 26:172-176.
46. Badovinac, V.P., Messingham, K.A., Hamilton, S.E., and Harty, J.T. 2003. Regulation of CD8+ T cells undergoing primary and secondary responses to infection in the same host. J. Immunol. 170:4933-4942.
47. Grayson, J.M., Harrington, L.E., Lanier, J.G., Wherry, E.J., and Ahmed, R. 2002. Differential sensitivity of naive and memory CD8+ T cells to apoptosis in vivo. J. Immunol. 169:3760-3770.
48. Williams, M.A., and Bevan, M.J. 2007. Effector and memory CTL differentiation. Annu. Rev. Immunol. 25:171-192.
49. Ahmed, R., Salmi, A., Butler, L.D., Chiller, J.M., and Oldstone, M.B. 1984. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160:521-540.
50. Sun, J.C., Williams, M.A., and Bevan, M.J. 2004. CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat. Immunol. 5:927-933.
51. Hassett, D.E., Zhang, J., Slifka, M., and Whitton, J.L. 2000. Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization. J. Virol. 74:2620-2627.
52. Martins, L.P., Lau, L.L., Asano, M.S., and Ahmed, R. 1995. DNA vaccination against persistent viral infection. J. Virol. 69:2574-2582.
53. Suresh, M., et al. 2003. Complement component 3 is required for optimal expansion of CD8 T cells during a systemic viral infection. J. Immunol. 170:788-794.
54. Kaech, S.M., Hemby, S., Kersh, E., and Ahmed, R. 2002. Molecular and functional profiling of memory CD8 T cell differentiation. Cell. 111:837-851.